Argenx Se (ARGX) Stock Forecast & Price Target

Compare

755 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

ARGX Analyst Ratings

Strong Buy

14 Buy

2 Hold

0 Sell

Based on 16 analysts giving stock ratings to

Argenx

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

ARGX Stock 12 Month Forecast

Average Price Target

$1,049.64

▲(24.92% Upside)

Based on 16 Wall Street analysts offering 12 month price targets for Argenx Se in the last 3 months. The average price target is $1,049.64 with a high forecast of $1,317.00 and a low forecast of $858.00. The average price target represents a 24.92% change from the last price of $840.28.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"541":"$541","1318":"$1,318","735.25":"$735.3","929.5":"$929.5","1123.75":"$1,123.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1317,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$1.32K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1049.64,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$1.05K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":858,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$858.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[541,735.25,929.5,1123.75,1318],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,835.68,872.7046153846153,909.7292307692308,946.7538461538461,983.7784615384614,1020.8030769230769,1057.8276923076924,1094.8523076923077,1131.876923076923,1168.9015384615384,1205.9261538461537,1242.9507692307693,1279.9753846153847,{"y":1317,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,835.68,852.1384615384615,868.5969230769231,885.0553846153846,901.5138461538461,917.9723076923077,934.4307692307692,950.8892307692308,967.3476923076923,983.8061538461538,1000.2646153846155,1016.723076923077,1033.1815384615386,{"y":1049.64,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,835.68,837.396923076923,839.1138461538461,840.8307692307692,842.5476923076923,844.2646153846154,845.9815384615384,847.6984615384615,849.4153846153846,851.1323076923077,852.8492307692308,854.5661538461538,856.2830769230769,{"y":858,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":655.13,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":624.67,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":567.09,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 42,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":639.9,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 51,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":584.605,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 56,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":542.47,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 55,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":673.8,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 58,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":706.41,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 54,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":767.33,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 67,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":818.5,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 48,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":894.9,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 48,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":840.95,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 66,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":835.68,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 63,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$1,317

Average Price Target$1,050

Lowest Price Target$858.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Akash Tewari

Jefferies

$980→$1,008

Buy

19.96%

Upside

Reiterated

02/19/26

Jefferies Sticks to Its Buy Rating for Argenx Se (ARGX)

Sean Laaman

Morgan Stanley

$1,160

Buy

38.05%

Upside

Reiterated

02/02/26

Morgan Stanley Remains a Buy on Argenx Se (ARGX)

Tazeen Ahmad

Bank of America Securities

$846.76→$1,006

Buy

19.72%

Upside

Reiterated

01/30/26

Analysts Offer Insights on Healthcare Companies: Intellia Therapeutics (NASDAQ: NTLA), Opus Genetics (NASDAQ: IRD) and Argenx Se (NASDAQ: ARGX)

Douglas Tsao

H.C. Wainwright

$915

Buy

8.89%

Upside

Reiterated

01/21/26

Analysts Offer Insights on Healthcare Companies: Argenx Se (NASDAQ: ARGX), Agenus (NASDAQ: AGEN) and Assertio Therapeutics (NASDAQ: ASRT)

Derek Archila

Wells Fargo

$1,264→$1,317

Buy

56.73%

Upside

Reiterated

01/20/26

Argenx Se (ARGX) Receives a Buy from Wells Fargo

Gavin Clark-Gartner

Evercore ISI

$1,007

Buy

19.84%

Upside

Reiterated

01/20/26

Argenx Se (ARGX) Receives a Buy from Evercore ISI

David Nierengarten

Wedbush

$1,000

Buy

19.01%

Upside

Reiterated

01/13/26

Wedbush Remains a Buy on Argenx Se (ARGX)

Xian Deng

UBS

$910→$900

Hold

7.11%

Upside

Reiterated

01/13/26

UBS Sticks to Its Hold Rating for Argenx Se (ARGX)

Danielle Brill

Truist Financial

―

Buy

―

Reiterated

01/13/26

Analysts Offer Insights on Healthcare Companies: Argenx Se (NASDAQ: ARGX), Travere Therapeutics (NASDAQ: TVTX) and Beyond Air (NASDAQ: XAIR)

Matt Phipps

William Blair

―

Buy

―

Reiterated

01/12/26

Argenx: Sustained Vyvgart Momentum and Expanding FcRn Pipeline Underpin Buy Rating and Attractive Risk‑Reward

Samantha Semenkow

Citi

$1,124→$1,091

Buy

29.84%

Upside

Reiterated

01/09/26

Citi Sticks to Their Buy Rating for Argenx Se (ARGX)

Luca Issi

RBC Capital

$925

Buy

10.08%

Upside

Reiterated

01/08/26

Analysts Offer Insights on Healthcare Companies: Nuvation Bio (NYSE: NUVB), Mediwound (NASDAQ: MDWD) and Argenx Se (NASDAQ: ARGX)

Yatin Suneja

Guggenheim

$1,085→$1,160

Buy

38.05%

Upside

Reiterated

12/18/25

Argenx price target raised to $1,160 from $1,085 at GuggenheimArgenx price target raised to $1,160 from $1,085 at Guggenheim

Colleen M. Kusy

Robert W. Baird

$924→$858

Hold

2.11%

Upside

Downgraded

12/18/25

argenx: Strong Growth and Pipeline Potential Already Priced In, Warranting a Neutral/Hold Rating

Alex Thompson CFA

Stifel Nicolaus

$1,028→$1,248

Buy

48.52%

Upside

Reiterated

12/11/25

Stifel Nicolaus Keeps Their Buy Rating on Argenx Se (ARGX)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Akash Tewari

Jefferies

$980→$1,008

Buy

19.96%

Upside

Reiterated

02/19/26

Jefferies Sticks to Its Buy Rating for Argenx Se (ARGX)

Sean Laaman

Morgan Stanley

$1,160

Buy

38.05%

Upside

Reiterated

02/02/26

Morgan Stanley Remains a Buy on Argenx Se (ARGX)

Tazeen Ahmad

Bank of America Securities

$846.76→$1,006

Buy

19.72%

Upside

Reiterated

01/30/26

Analysts Offer Insights on Healthcare Companies: Intellia Therapeutics (NASDAQ: NTLA), Opus Genetics (NASDAQ: IRD) and Argenx Se (NASDAQ: ARGX)

Douglas Tsao

H.C. Wainwright

$915

Buy

8.89%

Upside

Reiterated

01/21/26

Analysts Offer Insights on Healthcare Companies: Argenx Se (NASDAQ: ARGX), Agenus (NASDAQ: AGEN) and Assertio Therapeutics (NASDAQ: ASRT)

Derek Archila

Wells Fargo

$1,264→$1,317

Buy

56.73%

Upside

Reiterated

01/20/26

Argenx Se (ARGX) Receives a Buy from Wells Fargo

Gavin Clark-Gartner

Evercore ISI

$1,007

Buy

19.84%

Upside

Reiterated

01/20/26

Argenx Se (ARGX) Receives a Buy from Evercore ISI

David Nierengarten

Wedbush

$1,000

Buy

19.01%

Upside

Reiterated

01/13/26

Wedbush Remains a Buy on Argenx Se (ARGX)

Xian Deng

UBS

$910→$900

Hold

7.11%

Upside

Reiterated

01/13/26

UBS Sticks to Its Hold Rating for Argenx Se (ARGX)

Danielle Brill

Truist Financial

―

Buy

―

Reiterated

01/13/26

Analysts Offer Insights on Healthcare Companies: Argenx Se (NASDAQ: ARGX), Travere Therapeutics (NASDAQ: TVTX) and Beyond Air (NASDAQ: XAIR)

Matt Phipps

William Blair

―

Buy

―

Reiterated

01/12/26

Argenx: Sustained Vyvgart Momentum and Expanding FcRn Pipeline Underpin Buy Rating and Attractive Risk‑Reward

Samantha Semenkow

Citi

$1,124→$1,091

Buy

29.84%

Upside

Reiterated

01/09/26

Citi Sticks to Their Buy Rating for Argenx Se (ARGX)

Luca Issi

RBC Capital

$925

Buy

10.08%

Upside

Reiterated

01/08/26

Analysts Offer Insights on Healthcare Companies: Nuvation Bio (NYSE: NUVB), Mediwound (NASDAQ: MDWD) and Argenx Se (NASDAQ: ARGX)

Yatin Suneja

Guggenheim

$1,085→$1,160

Buy

38.05%

Upside

Reiterated

12/18/25

Argenx price target raised to $1,160 from $1,085 at GuggenheimArgenx price target raised to $1,160 from $1,085 at Guggenheim

Colleen M. Kusy

Robert W. Baird

$924→$858

Hold

2.11%

Upside

Downgraded

12/18/25

argenx: Strong Growth and Pipeline Potential Already Priced In, Warranting a Neutral/Hold Rating

Alex Thompson CFA

Stifel Nicolaus

$1,028→$1,248

Buy

48.52%

Upside

Reiterated

12/11/25

Stifel Nicolaus Keeps Their Buy Rating on Argenx Se (ARGX)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Argenx Se

3 Months

xxx

Success Rate

13/17 ratings generated profit

Average Return

+7.95%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 76.47% of your transactions generating a profit, with an average return of +7.95% per trade.

1 Year

Yaron WerberTD Cowen

Success Rate

29/31 ratings generated profit

Average Return

+44.96%

reiterated a buy rating 4 months ago

Copying Yaron Werber's trades and holding each position for 1 Year would result in 93.55% of your transactions generating a profit, with an average return of +44.96% per trade.

2 Years

xxx

Success Rate

31/31 ratings generated profit

Average Return

+70.85%

reiterated a xxx

rating 4 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +70.85% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ARGX Analyst Recommendation Trends

Rating

Oct 25

Nov 25

Dec 25

Jan 26

Feb 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, ARGX has received 63 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. ARGX average Analyst price target in the past 3 months is 1,049.64.

Each month's total comprises the sum of three months' worth of ratings.

ARGX Financial Forecast

ARGX Earnings Forecast

Currently, no earnings data available.

ARGX Sales Forecast

Currently, no sales data available.

ARGX Stock Forecast FAQ

What is ARGX’s average 12-month price target, according to analysts?

Based on analyst ratings, Argenx’s 12-month average price target is 1,049.64.

What is ARGX’s upside potential, based on the analysts’ average price target?

Argenx has 24.92% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is ARGX a Buy, Sell or Hold?

Argenx has a consensus rating of Strong Buy which is based on 14 buy ratings, 2 hold ratings and 0 sell ratings.

What is Argenx’s price target?

The average price target for Argenx is 1,049.64. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $1,317.00 ,the lowest forecast is $858.00. The average price target represents 24.92% Increase from the current price of $840.28.

What do analysts say about Argenx?

Argenx’s analyst rating consensus is a Strong Buy. This is based on the ratings of 16 Wall Streets Analysts.

How can I buy shares of ARGX?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Argenx Se (ARGX) Stock Forecast & Price Target

ARGX Analyst Ratings

ARGX Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Argenx Se

ARGX Analyst Recommendation Trends

ARGX Financial Forecast

ARGX Earnings Forecast

ARGX Sales Forecast

ARGX Stock Forecast FAQ

Detailed List of Analyst Forecasts